Background The Xpert MTB/RIF (Cepheid) non-laboratory-based molecular assay has
potential to improve the diagnosis of tuberculosis (TB), especially in HIV-infected …

Summary Background The Xpert MTB/RIF (Xpert) assay is used globally to rapidly diagnose
tuberculosis and resistance to rifampicin. We investigated the frequency and predictors of …

Evaluation of: Tortoli E, Russo C, Piersimoni C et al. Clinical validation of Xpert MTB/RIF for
the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. doi: 10.1183 …

Performance of the Xpert MTB/RIF assay, designed to simultaneously detect Mycobacterium
tuberculosis complex (MTBC) and rifampin (RIF) resistance, has been well documented in …

Summary Background The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect
tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in …

Rationale: Xpert MTB/RIF is a novel automated molecular diagnostic recently endorsed by
the World Health Organization. However, performance-related data from high HIV …

Background Global control of tuberculosis is hampered by slow, insensitive diagnostic
methods, particularly for the detection of drug-resistant forms and in patients with human …

Early diagnosis, including universal drug-susceptibility testing for all patients with
tuberculosis, remains a key priority for tuberculosis elimination by 2035. The drug-resistant …

Diagnostic accuracy of Xpert MTB/RIF assay for pulmonary tuberculosis (PTB) and
extrapulmonary TB (EPTB) has not been investigated in Iran. This study was aimed to …

Abstract Background. The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification
test widely used in settings of high tuberculosis prevalence to detect tuberculosis as well as …